DOUGLAS RICHARD - 08 Jun 2021 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Richard Douglas
Issuer symbol
ALDX
Transactions as of
08 Jun 2021
Net transactions value
$0
Form type
4
Filing time
10 Jun 2021, 17:46:58 UTC
Next filing
22 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +13,534 $0.000000 13,534 08 Jun 2021 Common Stock 13,534 $12.97 Direct F1
transaction ALDX Stock Option (Right to Buy) Award $0 +3,500 $0.000000 3,500 08 Jun 2021 Common Stock 3,500 $12.97 Direct F2
transaction ALDX Stock Option (Right to Buy) Award $0 +408 $0.000000 408 08 Jun 2021 Common Stock 408 $12.97 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date.
F3 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.